Visual Impairment News and Research

Latest Visual Impairment News and Research

UK charity establishes new funding opportunities to address sight loss

Fight for Sight is encouraging applicants to apply for the Project Grants Awards. The call for the £250k award to undertake a three year project, is now open.

14 May 2019

Microglia play vital role in regulating neuroinflammation, research shows

A research team at Massachusetts Eye and Ear has shown that microglia, the primary immune cells of the central nervous system--including the retina of the eye--serve as "gatekeepers," or biosensors and facilitators, of neuroinflammation in a preclinical model of autoimmune uveitis.

23 Apr 2019

Study provides new understanding of how the brain recovers from damage caused by stroke

Each year, approximately 265,000 Americans have a stroke that causes visual impairment. New research, which appears in the journal Proceedings of the Royal Society B, sheds light on how the damage in the brain caused by a stroke can lead to permanent vision impairment.

21 Mar 2019

Study highlights high incidence and prevalence of visual problems in stroke survivors

A new University study, published in PLOS ONE, highlights the high incidence and prevalence of visual problems in acute stroke survivors.

12 Mar 2019

Laser-based technique allows doctors to image the whole eye in 3D

Scientists have developed a laser-based technique that can produce a full 3D image of all the layers of the retina, allowing doctors to better diagnose and treat eye diseases such as cataracts, diabetic retinopathy, and cancer.

6 Mar 2019

Age-Related Macular Degeneration Awareness Month: How visual impairment affects older adults

As Age-Related Macular Degeneration/Low Vision Awareness Month comes to a close, we’re sharing three stories by Bonnielin Swenor, Ph.D., M.P.H., assistant professor of ophthalmology at the Wilmer Eye Institute in the Johns Hopkins University School of Medicine, and an assistant professor of epidemiology at the Johns Hopkins Bloomberg School of Public Health.

5 Mar 2019

Scientists develop new method to detect viral RNA without special equipment

Scientists from the SCAMT Laboratory of ITMO University developed a method to detect viral RNA without special equipment.

3 Dec 2018

Electronic shutter eyeglasses may be alternative treatment for amblyopic children in future

The standard treatment for so-called lazy eye (amblyopia) in children is to cover the nonimpaired eye with a patch. This trains the impaired eye to work harder. Such therapy is successful only when the patient wears the eyepatch for the prescribed period of time.

29 Nov 2018

Vision impairments may increase risk of falls in older adults

Vision impairment and blindness affect one in 11 Americans age 65 and older. Because our population is aging, the number of older adults with vision problems is predicted to rise.

19 Nov 2018

Gene editing could be used to halt kidney disease in patients with Joubert syndrome

For the first time scientists have identified how to halt kidney disease in a life-limiting genetic condition, which may pave the way for personalized treatment in the future.

16 Nov 2018

Increasing omega-3 fatty acid intake during pregnancy reduces risk of premature birth, review finds

A new Cochrane Review published today has found that increasing the intake of omega-3 long-chain polyunsaturated fatty acids during pregnancy reduces the risk of premature births.

15 Nov 2018

Calcified nodules in the retina increase risk for progression to late stages of AMD

Calcified nodules in the retina are associated with progression to late stages of age-related macular degeneration.

14 Nov 2018

Researchers to develop sports-specific classification system for blind football

The University of Chichester has been chosen to lead research into a developing a sports-specific classification system for blind football.

13 Nov 2018

Computer games and a summer birthday linked to increased risk of myopia in childhood

According to a new study by researchers in King's School of Life Course Sciences, time spent playing computer games and being born in the summer are both linked to an increased risk of developing short or near sightedness (myopia) in childhood.

8 Nov 2018

Maternal smoking during pregnancy associated with increased risk of strabismus in offspring

In an Acta Ophthalmologica analysis of 11 relevant articles, maternal smoking during pregnancy was associated with a 46 percent increased risk that offspring will develop strabismus—one of the most prevalent eye-related diseases among children.

7 Nov 2018

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

Pfizer Inc. today announced that the U.S. Food and Drug Administration has approved LORBRENA, a third-generation anaplastic lymphoma kinase tyrosine kinase inhibitor for patients with ALK-positive metastatic non-small cell lung cancer whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease; or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

5 Nov 2018

Researchers find a class of drug that could be promising treatment for uveitis

Ocular inflammation uveitis is a serious disease that can destroy eye tissue and cause irreversible blindness.

2 Nov 2018

Premature babies with low levels of blood platelets have increased risk of blindness

Premature babies with low levels of platelets (thrombocytes) in their blood run a greatly increased risk of being afflicted with a severe variation of retinopathy of prematurity, an eye disease that can cause blindness, according to a study from Sweden and US published in the journal JCI Insight.

11 Oct 2018

Molecular pathways underlying myopia open new ways for drug development

Myopia (nearsightedness) and hyperopia (farsightedness) develop through different molecular pathways, according to a new study publishing October 9 in the open-access journal PLOS Biology by Andrei Tkatchenko of Columbia University and colleagues.

10 Oct 2018

Pfizer announces FDA approval of VIZIMPRO for first-line treatment of EGFR-mutated metastatic NSCLC

Pfizer Inc. today announced that the U.S. Food and Drug Administration has approved VIZIMPRO [vih-ZIM-pro] (dacomitinib), a kinase inhibitor for the first-line treatment of patients with metastatic non-small cell lung cancer with epidermal growth factor receptor exon 19 deletion or exon 21 L858R substitution mutations as detected by an FDA-approved test.

28 Sep 2018

Visual Impairment News and Research

Latest Visual Impairment News and Research

UK charity establishes new funding opportunities to address sight loss

Microglia play vital role in regulating neuroinflammation, research shows

Study provides new understanding of how the brain recovers from damage caused by stroke

Study highlights high incidence and prevalence of visual problems in stroke survivors

Laser-based technique allows doctors to image the whole eye in 3D

Age-Related Macular Degeneration Awareness Month: How visual impairment affects older adults

Scientists develop new method to detect viral RNA without special equipment

Electronic shutter eyeglasses may be alternative treatment for amblyopic children in future

Vision impairments may increase risk of falls in older adults

Gene editing could be used to halt kidney disease in patients with Joubert syndrome

Increasing omega-3 fatty acid intake during pregnancy reduces risk of premature birth, review finds

Calcified nodules in the retina increase risk for progression to late stages of AMD

Researchers to develop sports-specific classification system for blind football

Computer games and a summer birthday linked to increased risk of myopia in childhood

Maternal smoking during pregnancy associated with increased risk of strabismus in offspring

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

Researchers find a class of drug that could be promising treatment for uveitis

Premature babies with low levels of blood platelets have increased risk of blindness

Molecular pathways underlying myopia open new ways for drug development

Pfizer announces FDA approval of VIZIMPRO for first-line treatment of EGFR-mutated metastatic NSCLC

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Visual Impairment News and Research

Latest Visual Impairment News and Research

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in